| Onjin Kim, MD | |
|
2360 E Pershing Blvd, Cheyenne, WY 82001-5356 | |
| (307) 778-7550 | |
| Not Available |
| Full Name | Onjin Kim |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 2360 E Pershing Blvd, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942542014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | ME130629 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Onjin Kim, MD 2360 E Pershing Blvd, Cheyenne, WY 82001-5356 Ph: () - | Onjin Kim, MD 2360 E Pershing Blvd, Cheyenne, WY 82001-5356 Ph: (307) 778-7550 |
News Archive
All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; and the School of Arts and Sciences, at the University of Pennsylvania, have developed a potent new drug that clogs up the recycling machinery and kills tumor cells in mouse models.
Headaches, back pain, arthritis and other aches distract employees and cost companies more than $61 billion a year in lost productive time, according to a study published in the Journal of the American Medical Association.
Kaiser Health News staff writer Julie Appleby reports on findings regarding Medicare drug plan costs: "The 10 insurers with the largest numbers of Medicare drug plan customers raised premiums an average of 10 percent this year, an analysis released Friday by consulting firm Avalere Health shows" (Appleby, 3/12).
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 1 days ago
Dr. Julie Anne Toshcoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 | |
Jie Chen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 18th St, Cheyenne, WY 82001 Phone: 307-633-7370 Fax: 307-633-7202 | |
Celina Frances Tolge, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2301 House Ave, Suite 203, Cheyenne, WY 82001 Phone: 307-432-0335 Fax: 307-432-0341 | |
Tracie Caller, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2301 House Ave Ste 201, Cheyenne, WY 82001 Phone: 307-638-7757 Fax: 307-638-8399 | |
Terri Orcutt, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 | |
Benjamin Tankever Johnson, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2600 E 18th St, Cheyenne, WY 82001 Phone: 307-633-7370 Fax: 307-637-7202 | |
Reed Clifton Shafer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5050 Powderhouse Rd, Cheyenne, WY 82009 Phone: 307-634-1311 Fax: 307-634-1271 |